drugset / Trial / NCT01321333

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury

NCT01321333

Phase 1/2 Completed 12 enrolled StemCells, Inc.
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the effect of single transplantation of HuCNS-SC cells into the thoracic spinal cord of patients with sub-acute spinal cord injury.

Timeline

Start
2011-03
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy Other

Indications